作者：
Vieira,M.L.T. [1]
;
Kirby,B. [2]
;
Ragueneau-Majlessi,I. [3]
;
Galetin,A. [4]
;
Chien,J.Y.L. [5]
;
Einolf,H.J. [6]
;
Fahmi,O.A. [7]
;
Fischer,V. [8]
;
Fretland,A. [9]
;
Grime,K. [10]
;
Hall,S.D. [11]
;
Higgs,R. [12]
;
Plowchalk,D. [13]
;
Riley,R. [14]
;
Seibert,E. ;
Skordos,K. ;
Snoeys,J. ;
Venkatakrishnan,K. ;
Waterhouse,T. ;
Obach,R.S. ;
Berglund,E.G. ;
Zhang,L. ;
Zhao,P. ;
Reynolds,K.S. ;
Huang,S.-M.
作者单位：
Millennium Pharmaceuticals, Cambridge, MA, United States
[1]
Eli Lilly and Company, Indianapolis, IN, United States
[2]
Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, United States
[3]
Janssen Pharmaceutical Companies of Johnson and Johnson, Beerse, Belgium
[4]
University of Washington, Seattle, WA, United States
[5]
Pfizer Inc., Groton, CT, United States
[6]
AstraZeneca Research and Development, M?lndal, Sweden
[7]
GlaxoSmithKline, Research Triangle Park, NC, United States
[8]
AstraZeneca Research and Development, Alderley Park, United Kingdom
[9]
Novartis, East Hanover, NJ, United States
[10]
AbbVie, North Chicago, IL, United States
[11]
University of Manchester, Greater Manchester, United Kingdom
[12]
Medical Products Agency, Uppsala, Sweden
[13]
US Food and Drug Administration, Silver Spring, MD, United States
[14]
发布时间
2018-07-27
换一批
